Interindividual heterogeneity in the hypoxic regulation of VEGF: Significance for the development of the coronary artery collateral circulation

Circulation

Volumn 100, Issue 5, 1999, Pages 547-552

  Schultz, Aylit ^a   Lavie, Lena ^a   Hochberg, Irit ^a,b   Beyar, Rafael ^a,b   Stone, Tzachi ^a   Skorecki, Karl ^a,b   Lavie, Peretz ^a   Roguin, Ariel ^b   Levy, Andrew P ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Angiogenesis; Collateral circulation; Growth substances; Hypoxia; Ischemia

Indexed keywords

ANGIOGENIC FACTOR; GROWTH PROMOTOR; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORRELATION FUNCTION; DIABETIC RETINOPATHY; FEMALE; GENETIC HETEROGENEITY; HUMAN; HYPOXIA; ISCHEMIA; MALE; MONOCYTE; PRIORITY JOURNAL;

EID: 0033520043     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.5.547     Document Type: Article

References (34)

1. Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, Bolli R. Influence of coronary artery collaterals on myocardial infarct size in humans: results of phase 1 thrombolysis in myocardial infarction (TIMI) trial. Circulation. 1991;83:739-746.
2. Hansen J. Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J. 1989;117:290-295.
3. Baroldi G. Coronary heart disease: significance of the morphologic lesions. Am Heart J. 1973;85:1-5.
4. Schaper W, DeBrabander M, Lewi P. DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res. 1971;28:671-679.
5. Adair TH, Gay WJ, Montani JP. Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am J Physiol. 1990;259: R393-R404.
6. Folkman J. Tumor angiogenesis. Adv Cancer Res. 1985;43:175-203.
7. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
8. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-845.
9. Levy A, Levy NS, Loscalzo J, Calderone A, Takahashi N, Yeo KT, Koren G, Colucci WS, Goldberg MA. Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res. 1995;76:758-766.
10. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E. Upregulation of vascular endothelial growth factor induced by myocardial ischemia: implications for coronary angiogenesis. Cardiovasc Res. 1994;28:1176-1179.
11. Knighton DR, Hunt TK, Scheueenstuhl H, Halliday BJ, Werb Z, Banda MJ. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science. 1983;221:1283-1285.
12. Xiong M, Elson G, Legardo D, Leibovitch SJ. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate and the inducible NO synthetase pathway. Am J Pathol. 1998; 153:587-598.
13. Harmey JH, Dimitriadis E, Kay E, Redmond HP, Bouchier-Hayes D. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1. Ann Surg Oncol. 1998;5:271-278.
14. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest. 1998;101:40-50.
15. Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest. 1968;21(suppl 97):77-89.
16. Ramamurthy S, Sharma S, Kumar RK, Rajani M, Wasir HS. Collateral arteries in the presence of obstructive coronary disease. Natl Med J India. 1994;7:260-262.
17. Ilia R, Carmel S, Gueron M. Patients with coronary collaterals and normal left ventricular systolic function: clinical, hemodynamic, and angiographic characteristics. Angiology. 1998;49:631-635.
18. Kyriakides ZS, Kresmastinos DT, Michelakakis NA, Matsakas EP, Demovelis T, Toutouzas PK. Coronary collateral circulation in coronary artery disease and systemic hypertension. Am J Cardiol. 1991;67: 687-690.
19. Yarom R, Zirkin H, Stammler G, Rose AG. Human coronary microvessels in diabetes and ischaemia: morphometric study of autopsy material. J Pathol. 1992;166:265-270.
20. Karpanou EA, Vyssoulis GP, Skoumas JN, Zervopoulos GA, Moundaki VS, Toutouzas PK. Significance of arterial hypertension on coronary collateral circulation development and left ventricular function in coronary artery disease. J Hypertens Suppl. 1988;6:S151-S153.
21. Morimoto S, Hiasa Y, Hamai K, Wada T, Aihara T, Kataoka Y, Mori H. Influence factors on coronary collateral development. Kokyu To Junkan. 1989;37:1103-1107.
22. Heinle RA, Levy RI, Gorlin R. Effects of factors predisposing to atherosclerosis on formation of coronary collateral vessels. Am J Cardiol. 1974;33:12-16.
23. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem. 1995; 270:13333-13340.
24. Levy AP, Levy NS, Goldberg MA. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem. 1996;271: 2746-2753.
25. 2 tension. Proc Natl Acad Sci USA. 1995;92:5510-5514.
26. Ma W, Cheng S, Campbell C, Wright A, Furneaux HM. Cloning and characterization of HuR, a ubiquitously expressed elav-like protein. J Biol Chem. 1996;271:8144-8151.
27. Levy NS, Chang S, Furneaux HM, Levy AP. Hypoxic stabilization of VEGF mRNA by the RNA binding protein HuR. J Biol Chem. 1998;273: 6417-6423.
28. Sogawa K, Numayama-Tsuruta K, Ema M, Abe M, Abe H, Fujii-Kuriyama Y. Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia. Proc Natl Acad Sci USA. 1998;95:7368-7373.
29. Scott PA, Gleadle JM, Bicknell R, Harris AL. Role of hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. Int J Cancer. 1998;75:706-712.
30. Banai S, Jaklitsch T, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Linger EF. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994;89:2183-2189.
31. Takeshita S, Zheng L, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis: a single intrarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest. 1994;93: 662-670.
32. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JM. Constitutive expression of phVEGF 165 after intramuscular gene transfer promotes collateral development in patients with critical limb ischemia. Circulation. 1998;97:1114-1124.
33. Plate KH, Breier HA, Weich A, Risau W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature. 1992;359:845-848.
34. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JF, Nguyen HV, Aiello LM, Ferrara N, King G. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.